Your browser doesn't support javascript.
loading
Therapeutic targeting of metabolic vulnerabilities in cancers with MLL3/4-COMPASS epigenetic regulator mutations.
Zhao, Zibo; Cao, Kaixiang; Watanabe, Jun; Philips, Cassandra N; Zeidner, Jacob M; Ishi, Yukitomo; Wang, Qixuan; Gold, Sarah R; Junkins, Katherine; Bartom, Elizabeth T; Yue, Feng; Chandel, Navdeep S; Hashizume, Rintaro; Ben-Sahra, Issam; Shilatifard, Ali.
Afiliação
  • Zhao Z; Department of Biochemistry and Molecular Genetics.
  • Cao K; Simpson Querrey Center for Epigenetics.
  • Watanabe J; Department of Biochemistry and Molecular Genetics.
  • Philips CN; Simpson Querrey Center for Epigenetics.
  • Zeidner JM; Department of Biochemistry and Molecular Genetics.
  • Ishi Y; Robert H. Lurie NCI Comprehensive Cancer Center, and.
  • Wang Q; Department of Biochemistry and Molecular Genetics.
  • Gold SR; Simpson Querrey Center for Epigenetics.
  • Junkins K; Department of Biochemistry and Molecular Genetics.
  • Bartom ET; Simpson Querrey Center for Epigenetics.
  • Yue F; Department of Biochemistry and Molecular Genetics.
  • Chandel NS; Robert H. Lurie NCI Comprehensive Cancer Center, and.
  • Hashizume R; Department of Biochemistry and Molecular Genetics.
  • Ben-Sahra I; Simpson Querrey Center for Epigenetics.
  • Shilatifard A; Department of Biochemistry and Molecular Genetics.
J Clin Invest ; 133(13)2023 07 03.
Article em En | MEDLINE | ID: mdl-37252797

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Proteômica / Neoplasias Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Proteômica / Neoplasias Idioma: En Ano de publicação: 2023 Tipo de documento: Article